Arcus Biosciences, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
RCUS on NYSE
Industry
Pharmaceutical Preparations
Location
3928 Point Eden Way, Hayward, California

Insiders trading volume in the past year

Arcus Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gilead Sciences, Inc. 10%+ Owner $631M +$320M +103% Jan 29, 2024
Terry J. Rosen Chief Executive Officer, Director $67.1M Jun 15, 2024
Juan C. Jaen President $25.8M -$683K -2.58% Jun 15, 2024
Yasunori Kaneko Director $16.1M Jun 6, 2024
Jennifer Jarrett Chief Operating Officer $3.45M -$2.43M -41.4% Jun 15, 2024
Kathryn E. Falberg Director $2.76M Jun 6, 2024
Dimitry SA Nuyten Chief Medical Officer $1.98M Jan 23, 2024
Carolyn Tang General Counsel $1.89M Jun 15, 2024
Robert Goeltz II Chief Financial Officer $1.55M -$40.1K -2.52% Jan 23, 2024
David L. Lacey Director $1.01M Jun 6, 2024
Antoni Ribas Director $683K Jun 6, 2024
Andrew J. Perlman Director $515K Jun 6, 2024
Patrick Machado Director $444K Jun 6, 2024
Nicole Lambert Director $421K Jun 6, 2024
William Grossman Chief Medical Officer $414K Jun 16, 2021
Alexander Azoy Chief Accounting Officer $285K -$24.5K -7.91% Aug 13, 2024
Johanna Mercier Director $0 Jan 29, 2024
Linda Slanec Higgins Director Aug 10, 2021

Recent Insider Transactions by Companies or Individuals for Arcus Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.